Franklin Resources Inc Agenus Inc Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.53 - $0.93 $204,677 - $359,151	386,184 Added 236.31%	549,608 $318,000
Q4 2023 Feb 09, 2024	SELL	$0.63 - $1.14 $205 - $371	-326 Reduced 0.2%	163,424 $135,000
Q3 2023 Nov 13, 2023	BUY	$1.12 - $1.88 $228 - $383	204 Added 0.12%	163,750 $185,000
Q2 2023 Aug 11, 2023	BUY	$1.31 - $2.04 $214,245 - $333,633	163,546 New	163,546 $261,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.